Total Payments
$28,415
2024 Payments
$753.31
Companies
72
Transactions
700
Medicare Patients
1,621
Medicare Billing
$432,296
Payment Breakdown by Category
Other$15,379 (54.1%)
Food & Beverage$11,780 (41.5%)
Travel$1,239 (4.4%)
Education$17.55 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,379 | 19 | 54.1% |
| Food and Beverage | $11,780 | 676 | 41.5% |
| Travel and Lodging | $1,239 | 3 | 4.4% |
| Education | $17.55 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $13,360 | 27 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $2,381 | 14 | $0 (2022) |
| LivaNova USA, Inc. | $2,297 | 20 | $0 (2022) |
| EMD Serono, Inc. | $1,060 | 122 | $0 (2023) |
| ABBVIE INC. | $1,013 | 73 | $0 (2024) |
| GENZYME CORPORATION | $698.77 | 31 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $509.52 | 42 | $0 (2024) |
| Genentech USA, Inc. | $498.79 | 25 | $0 (2020) |
| Medtronic USA, Inc. | $486.86 | 7 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $411.75 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $753.31 | 39 | ABBVIE INC. ($197.62) |
| 2023 | $1,179 | 66 | ABBVIE INC. ($501.59) |
| 2022 | $3,466 | 77 | Biohaven Pharmaceutical Holding Company Ltd. ($2,381) |
| 2021 | $14,184 | 76 | Biohaven Pharmaceuticals, Inc. ($13,360) |
| 2020 | $1,120 | 76 | Teva Pharmaceuticals USA, Inc. ($205.99) |
| 2019 | $4,065 | 149 | LivaNova USA, Inc. ($1,971) |
| 2018 | $1,980 | 138 | EMD Serono, Inc. ($315.99) |
| 2017 | $1,668 | 79 | Medtronic USA, Inc. ($252.93) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: Neurology | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.85 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/28/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.24 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: NEUROLOGY | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: Neurology | ||||||
| 08/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: Neurology | ||||||
| 06/02/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: NEUROLOGY | ||||||
| 05/21/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Neurology | ||||||
| 05/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Central Nervous System | ||||||
| 04/23/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $13.60 | General |
| 04/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Neuroscience | ||||||
| 03/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 308 | 10,426 | $235,072 | $81,881 |
| 2022 | 10 | 313 | 15,131 | $309,157 | $108,848 |
| 2021 | 17 | 455 | 14,469 | $296,422 | $114,900 |
| 2020 | 18 | 545 | 17,389 | $378,925 | $126,667 |
Total Patients
1,621
Total Services
57,415
Medicare Billing
$432,296
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 21 | 9,915 | $127,125 | $45,438 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 235 | $53,354 | $18,548 | 34.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 20 | 47 | $22,484 | $5,130 | 22.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 42 | $8,064 | $4,178 | 51.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 57 | $6,213 | $3,449 | 55.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 46 | $6,578 | $2,433 | 37.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $6,674 | $2,064 | 30.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 50 | $4,433 | $496.79 | 11.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 21 | $147.00 | $144.06 | 98.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 27 | 14,577 | $173,112 | $66,440 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 285 | $61,067 | $23,154 | 37.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 22 | 56 | $24,332 | $6,260 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 60 | $8,297 | $3,625 | 43.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $9,926 | $2,973 | 30.0% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 11 | 21 | $12,148 | $2,674 | 22.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 11 | 22 | $14,142 | $2,306 | 16.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $1,617 | $780.22 | 48.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 61 | $4,390 | $585.41 | 13.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 18 | $126.00 | $50.62 | 40.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 28 | 13,700 | $154,850 | $62,879 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 349 | $59,439 | $29,977 | 50.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $11,208 | $5,042 | 45.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 23 | 43 | $16,624 | $4,694 | 28.2% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 13 | 27 | $13,751 | $2,821 | 20.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 50 | $5,874 | $2,801 | 47.7% |
About Dr. Sydney Piercey, MD
Dr. Sydney Piercey, MD is a Neurology healthcare provider based in Ogden, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104875855.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sydney Piercey, MD has received a total of $28,415 in payments from pharmaceutical and medical device companies, with $753.31 received in 2024. These payments were reported across 700 transactions from 72 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,379).
As a Medicare-enrolled provider, Piercey has provided services to 1,621 Medicare beneficiaries, totaling 57,415 services with total Medicare billing of $432,296. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Ogden, UT
- Active Since 05/09/2006
- Last Updated 03/17/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1104875855
Products in Payments
- NURTEC ODT (Drug) $15,766
- VNS Therapy (Device) $2,186
- UBRELVY (Drug) $559.02
- ACTIVA (Device) $486.86
- Rebif (Biological) $415.91
- AUBAGIO (Drug) $415.82
- OCREVUS (Biological) $401.25
- APTIOM (Drug) $355.46
- TYSABRI (Biological) $344.82
- AJOVY (Biological) $307.83
- ZEPOSIA (Drug) $294.36
- NUPLAZID (Drug) $293.15
- GOCOVRI (Drug) $289.44
- BOTOX (Biological) $272.24
- QULIPTA (Drug) $227.88
- EMGALITY (Drug) $205.74
- APOKYN (Drug) $204.55
- Mavenclad (Drug) $200.98
- KESIMPTA (Drug) $192.72
- Mavenclad (Biological) $191.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Ogden
Richard Hammond, Do, DO
Neurology — Payments: $735,946
Neurology $735,946
Dr. Trevor Squire, D.o, D.O
Neurology — Payments: $114,127
Neurology $114,127
Tyler Okelberry, Md, MD
Neurology — Payments: $274.44
Neurology $274.44
Preston Erickson
Neurology — Payments: $150.98
Neurology $150.98
Lindsey Lauritsen
Neurology
Neurology
Jessica Voorhees
Neurology
Neurology